XERS News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$1.88B

Volume

1.94M

Next Earnings

November 5th

Mkt Cap

$1.88B

Volume

1.94M

Next Earnings

November 5th

Chart Financials Earnings News About Insider Filings

Xeris (XERS) Q2 Revenue Jumps 49%Xeris Biopharma reported strong Q2 2025 financial results, with revenue jumping 48.8% year-over-year to $71.5 million, driven by significant growth in Recorlev sales. The company raised its full-year revenue guidance and showed a positive turn in adjusted EBITDA.The Motley Fool · Aug 7, 2025

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue EstimatesXeris Biopharma (XERS) delivered earnings and revenue surprises of -16.67% and 2.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 9, 2024

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?MediWound (MDWD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.Zacks Investment Research · Apr 17, 2024

Xeris Biopharma: Checking-In On One Of My 'Top Ideas'Xeris Biopharma's financial success in compounding healthcare investing may be uncertain due to competition and FDA approval risks. Read more on XERS stock here.Seeking Alpha · Mar 30, 2024

Why Xeris (XERS) Might Surprise This Earnings SeasonXeris (XERS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.Zacks Investment Research · Mar 5, 2024

Xeris (XERS) Up on Licensing Deal With Amgen to Develop TepezzaXeris (XERS) gains 16% after signing a licensing deal with Amgen, which allows the latter to utilize the XeriJect technology to develop a subcutaneous formulation of teprotumumab in Thyroid Eye Disease.Zacks Investment Research · Jan 11, 2024

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. WD-40 reported quarterly earnings of $1.28 per share which exceeded the analyst consensus estimate of $1.05 per share. The company reported quarterly sales of $140.42 million, clocking in above the Street's estimate of $134.37 million. WD-40 shares jumped 17.3% to $277.56 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Nauticus Robotics, Inc. (NASDAQ: KITT) climbed 87.8% to $0.5501. Nauticus Robotics secured additional funding and appointed John W. Gibson, Jr as interim CEO. Clearmind Medicine Inc. (NASDAQ: CMND) shares jumped 47.7% to $3.0570. Clearmind Medicine completed a Type A Meeting with the FDA for clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of alcohol use disorder. Sana Biotechnology, Inc. (NASDAQ: SANA) gained 46.8% to $7.57. Sana Biotechnology recently announced FDA clearance of investigational new drug application for SC262. Ucommune International Ltd (NASDAQ: UK) jumped 37.8% to $4.98. Vicarious Surgical Inc. (NASDAQ: RBOT) rose 37% to $0.6851. Nvni Group Limited (NASDAQ: NVNI) climbed 35.2% to $2.6091. EchoStar Corporation (NASDAQ: SATS) gained 31% to $16.50. EchoStar completed merger with DISH Network Corporation. Amarin Corporation plc (NASDAQ: AMRN) climbed 28.8% to $1.25 after the company reported strong preliminary FY23 total revenues. Exicure, Inc. (NASDAQ: XCUR) shares rose 17% to $0.5501. Exicure was granted broad U.S. patent #11866700 for "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin ...Benzinga · Jan 10, 2024

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On ThursdayU.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following better-than-expected quarterly results. Lamb Weston posted adjusted earnings of $1.45 per share, beating market estimates of $1.41 per share. The company’s quarterly sales came in at $1.73 billion versus estimates of $1.70 billion. Lamb Weston shares gained 4.7% to $109.86 on Thursday. Here are some other big stocks recording gains in today’s session. Omega Therapeutics, Inc. (NASDAQ: OMGA) gained 92.7% to $5.26 after Novo Nordisk entered into a research collaboration with the company. QuantumScape Corporation (NYSE: QS) jumped 18.5% to $7.70. Keros Therapeutics, Inc. (NASDAQ: KROS) rose 15.7% to $47.72. Keros Therapeutics priced upsized $140 million public offering of ...Benzinga · Jan 4, 2024

11 Top Penny Stocks To Buy Now According To InsidersPenny stocks to buy according to insiders this month. The post 11 Top Penny Stocks To Buy Now According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Nov 17, 2023

Penny Stocks to Buy? 3 To Watch With Insider Trading In NovemberPenny stocks to buy now according to insiders but are they right? The post Penny Stocks to Buy? 3 To Watch With Insider Trading In November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · Nov 16, 2023

XERSXeris Biopharma Holdings, Inc. Common Stock

XERS

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any XERS yet.

Related Tickers

Earnings

Mkt Cap

$1.88B

Volume

1.94M

Next Earnings

November 5th